Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DXR vs AWX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AWX Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–6 Matrix Metrics)

AWX Overall Winner 6-Pillar Tally: DXR 2 – 3 AWX (1 Tie) Matrix Metrics: DXR 6 – 4 AWX

As of Nov 16, 2026, Avalon Holdings Corp. (AWX) is the stronger overall head-to-head candidate over Daxor Corporation (DXR) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). DXR carries a Unified Composite Score of 52.2/100 (HOLD) at $8.36 (64.5x Forward P/E, -5894.3% operating margin), whereas AWX carries 37.7/100 (SELL) at $2.83 (36.2x Forward P/E, 6.5% operating margin).

  • Composite vs. Pillar Nuance: While DXR currently prints a higher short-term Unified Composite Score (52.2/100 HOLD vs. AWX 37.7/100 SELL), AWX captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (6.5% vs. -5894.3% operating margin) and revenue trajectory (+3.2% vs. +25.5% YoY).
  • Technical & Structure Timing Caution: DXR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.2); meanwhile AWX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 63.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DXR vs AWX
DXR NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap $49.5M
TTM Revenue $31,360
Forward P/E 64.5x
Beta / 30D Vol 0.28β · 32% Vol
Unified Composite Score
52.2 / 100 HOLD
Tech 52.0 Fund 59.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 31
RSI-14: 31.2 · SMA20: $8.91 · SMA50: $10.07
AWX NYSE American Head-to-Head Winner
Avalon Holdings Corp.
Refuse Systems
$2.83
+0.53% 1D
Market Cap $11.0M
TTM Revenue $143M
Forward P/E 36.2x
Beta / 30D Vol 0.35β · 46% Vol
Unified Composite Score
37.7 / 100 SELL
Tech 5.0 Fund 35.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 63
RSI-14: 63.4 · SMA20: $2.64 · SMA50: $2.59

6-Pillar Scorecard Institutional Category Breakdown (DXR 2 – 3 AWX)

Columns: Metric · DXR · AWX
1. Valuation Multiples AWX
Forward P/E 64.5x 36.2x
Trailing P/E 7.7x 5.5x
PEG Ratio N/M 4.39x
EV / Revenue N/M 0.1x
2. Growth & Scale DXR
Revenue Growth (YoY) +25.5% +3.2%
Earnings Growth (YoY) +329.3% +222.6%
TTM Revenue (USD) $31,360 $143M
Market Cap $49.5M $11.0M
3. Profitability & Quality DXR
Gross Margin 100.0% 20.5%
Operating Margin -5894.3% 6.5%
Net Profit Margin 19861.4% 1.4%
Return on Equity (ROE) 14.2% 2.5%
4. Balance Sheet & Cash Flow AWX
Cash Generation (TTM) N/A $5.6M
Cash Flow Margin N/A 3.9%
Net Cash / Leverage $8.88 Book/Sh · 14.2% ROE $9.84 Book/Sh · 2.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat AWX
OpEx & R&D Intensity N/A 14.0% of Rev ($20M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Instruments & Supplies Operator Waste Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DXR (6) vs AWX (4)
Institutional Metric DXR AWX Criterion Row Edge
Market Capitalization
Scale
$49.5M $11.0M Larger Scale DXR
Trailing P/E Ratio
Valuation
7.7x 5.5x Lower Multiple AWX
Forward P/E Ratio
Valuation
64.5x 36.2x Lower Multiple AWX
Revenue Growth (YoY)
Growth
+25.5% +3.2% Higher Growth DXR
Operating Margin (TTM)
Profitability
-5894.3% 6.5% Higher Margin AWX
Net Profit Margin
Profitability
19861.4% 1.4% Higher Margin DXR
Return on Equity (ROE)
Capital Efficiency
14.2% 2.5% Higher ROE DXR
52-Week Range Position
Momentum
2% ($8–$15) 71% ($2–$3) Stronger Trend AWX
Beta / 30D Volatility
Risk Regime
0.28β · 32% Vol 0.35β · 46% Vol Lower Realized Risk DXR
Unified Institutional Score
Composite Signal
52.2 / 100 (HOLD) 37.7 / 100 (SELL) Higher Composite DXR
Trailing 12M Revenue (USD)
Operating Scale
$31,360 $143M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 20.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 4.39x PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.88 Book/Sh · 14.2% ROE) $5.6M ($9.84 Book/Sh · 2.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AWX +30.07 pp
DXR: -16.87% · AWX: +13.2%
3M Horizon AWX +20.73 pp
DXR: -19.66% · AWX: +1.07%
6M Horizon AWX +30.64 pp
DXR: -17.44% · AWX: +13.2%
1Y Horizon AWX +33.27 pp
DXR: -33.27% · AWX: +0.0%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DXR vs AWX. Trailing 12-month operating profitability (DXR -5894.3% vs AWX 6.5%) and valuation multiples (DXR 64.5x vs AWX 36.2x Forward P/E) are benchmarked directly in Pillar 4 below.

DXR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$31,360
Gross Margin100.0%
Op. Margin-5894.3%
ROE / Fwd P/E14.2% · 64.5x
AWX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$143M
Gross Margin20.5%
Op. Margin6.5%
ROE / Fwd P/E2.5% · 36.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DXR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DXR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AWX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AWX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DXR Moat Profile Cyclical / Execution-Driven Positioning
Medical Instruments & Supplies Operator
Competes within the Medical Instruments & Supplies value chain with $49.5M market capitalization and -5894.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AWX Moat Profile Cyclical / Execution-Driven Positioning
Waste Management Operator
Competes within the Waste Management value chain with $11.0M market capitalization and 6.5% operating margin.
OpEx & R&D Reinvestment 14.0% of Rev ($20M)
90D Engineering Disclosures 0 Published

Investor FAQ DXR vs AWX Key Questions & Quantitative Answers

As of Nov 16, 2026, Avalon Holdings Corp. (AWX) is the stronger overall head-to-head candidate over Daxor Corporation (DXR) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). DXR carries a Unified Composite Score of 52.2/100 (HOLD) at $8.36 (64.5x Forward P/E, -5894.3% operating margin), whereas AWX carries 37.7/100 (SELL) at $2.83 (36.2x Forward P/E, 6.5% operating margin). Composite vs. Pillar Nuance: While DXR currently prints a higher short-term Unified Composite Score (52.2/100 HOLD vs. AWX 37.7/100 SELL), AWX captures the overall institutional head-to-head verdict (4–6 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (6.5% vs. -5894.3% operating margin) and revenue trajectory (+3.2% vs. +25.5% YoY). Technical & Structure Timing Caution: DXR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.2); meanwhile AWX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 63.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DXR leads the Growth & Scale pillar: DXR posts +25.5% YoY revenue growth and +329.3% YoY earnings growth on $31,360 TTM revenue (100.0% gross margin, -5894.3% operating margin), compared with AWX at +3.2% YoY revenue growth and +222.6% YoY earnings growth on $143M TTM revenue (20.5% gross margin, 6.5% operating margin). On trailing 12-month operating scale, DXR generates $31,360 in USD-normalized revenue versus $143M for AWX. In operating R&D and SG&A reinvestment, DXR deploys N/A (0 90-day corporate R&D disclosures) versus 14.0% of Rev ($20M) (0 disclosures) for AWX.

AWX screens cheaper on headline valuation multiples. DXR trades at 64.5x Forward P/E, 7.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AWX trades at 36.2x Forward P/E, 5.5x Trailing P/E, 4.39x PEG, and 0.1x EV/Revenue (3.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DXR (14.2% ROE) versus AWX (2.5% ROE) capital efficiency.

In options market volatility and institutional positioning, DXR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 32% Vol realized risk). By comparison, AWX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.35β · 46% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.